Vincerx Pharma, Inc. Common Stock
VINC
VINC was delisted on the 22nd of April, 2025.
0 hedge funds and large institutions have $0 invested in Vincerx Pharma, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $2 → $0 (-$2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTC
Bank & Trust Company
Litchfield,
Illinois
|
-$2 |
VINC Hedge Fund Activity: Q3 2025 in Review
0 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Common Stock (VINC) for Q3 2025, worth a combined $0 — down 100% from $2 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VINC and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Bank & Trust Company, exiting entirely with an estimated $2 sold.
- 0 institutional investors held Vincerx Pharma, Inc. Common Stock (VINC) as of Q3 2025, down from 1 in Q2 2025.
- Funds reported $0 of Vincerx Pharma, Inc. Common Stock stock for Q3 2025, down 100% quarter-over-quarter.
- 0 funds opened new Vincerx Pharma, Inc. Common Stock positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest Vincerx Pharma, Inc. Common Stock seller in Q3 2025 was Bank & Trust Company, an estimated $2 sold.
Based on aggregated 13F filings for Q3 2025.